Add this topic to your myFT Digest for news straight to your inbox
Doctors have to act as financial planners to find treatment that patients can afford
US stocks lack direction after post-payrolls record
Acquisitive biotech signs deal worth up to $2.6bn as drugmakers bet on experimental medicines
All mid-sized biotechs get bought eventually
Latest breakthroughs help create array of powerful drugs
Energy companies under pressure amid sharp decline in price of oil
GSK, Amgen and Celgene among groups teaming up for Cancer Moonshot 2020 to trial experimental drugs
US group to develop arthritis drug with Belgian biotech firm
UK drugmaker has option to buy remainder of US-Dutch biotech company for about $7bn
Companies with drugs already in clinical testing are being evaluated
Nasdaq Biotechnology index drops as low as 23.4% from July peak
Acquisition of Receptos could have been made for fraction of purchase amount less than two years ago
Companies that struggle to innovate may not be best placed to judge the quality of others’ ideas
US group has made a series of bold, some would say risky, bets
If inflation is gone forever, it’s hard to overpay for future growth
Acquisition is latest of a string of big deals in a race to build a pipeline of new drugs
Investment is equivalent to a premium of nearly 100% to Monday’s close
Technology-heavy index powered by Yellen comments on plan to raise rates slowly
Big pharma groups pay higher charges for access to most promising molecules
International Edition